Publikációk

Év	Szerző	Cím	Folyóirat	Forrás	Nyelv
2009	Nagy N, Szuts V, Horváth Z, Seprényi G, Farkas AS, Acsai K, Prorok J, Bitay M, Kun A, Pataricza J, Papp JG, Nánási PP, Varró A, Tóth A.	Does small-conductance calcium-activated potassium channel contribute to cardiac repolarization?	Journal of Molecular and Cellular Cardiology.	J Mol Cell Cardiol. 2009 Nov; 47(5): 656-63.	angol
2009	Prorok J, Kovács PP, Kristóf AA, Nagy N, Tombácz D, Tóth JS, Ordög B, Jost N, Virág L, Papp JG, Varró A, Tóth A, Boldogkoi Z.	Herpesvirus-mediated delivery of a genetically encoded fluorescent Ca(2+) sensor to canine cardiomyocytes.	Journal of Biomedicine and Biotechnology.	J Biomed Biotechnol. 2009; 2009: 361795.	angol
2009	Varró A.	Sportolók hirtelen szívhalála.	Lege Artis Medicin?.	LAM 2009; 19 (02)	magyar
2010	Bárándi L, Virág L, Jost N, Horváth Z, Koncz I, Papp R, Harmati G, Horváth B, Szentandrássy N, Bányász T, Magyar J, ZazaA, Varró A, Nánási PP.	Reverse rate-dependent changes are determined by baseline action potential duration in mammalian and human ventricular preparations.	Basic Research in Cardiology.	Basic Res Cardiol. 2010 May; 105(3):315-23.	angol
2010	Varró A, Baczkó I.	Possible mechanisms of sudden cardiac death in top athletes: a basic cardiac electrophysiological point of view.	Pflügers Archiv : European journal of physiology.	Pflugers Arch. 2010 Jun; 460 (1):31-40.	angol
2011	Lengyel C, Orosz A, Hegyi P, Komka Z, Udvardy A, Bosnyák E, Trájer E, Pavlik G, Tóth M, Wittmann T, Papp JG, Varró A, Baczkó I.	Increased short-term variability of the QT interval in professional soccer players: possible implications for arrhythmia prediction.	PLoSOne.	PLo S One. 2011 Apr 15; 6(4) :e18751.	angol
2011	Nagy N, Márton Z, Kiss L, Varró A, Nánási PP, Tóth A.	Role of Ca?+-sensitive K+ current sin controlling ventricular repolarization: possible implications for future antiarrhythmic drug therapy.	Current Medicinal Chemistry	Curr Med Chem. 2011; 18 (24): 3622-39.	angol
2011	O'Hara T, Virág L, Varró A, Rudy Y.	Simulation of the diseased human cardiac ventricular action potential: model formulation and experimental validation.	PLoS Computational Biology	PLoS Comput Biol. 2011 May; 7(5):e1002061.	angol
2011	Pueyo E, CorriasA, Virág L, Jost N, Szél T, Varró A, Szentandrássy N, Nánási PP, Burrage K, Rodríguez B.	A multi-scale investigation of repolarization variability and its olein cardiac arrhythmo genesis.	Biophysical Journal	Biophys J. 2011 Dec 21; 101(12):2892-902.	angol
2011	Szél T, Koncz I, Jost N, Baczkó I, Husti Z, Virág L, BussekA, Wettwer E, Ravens U, Papp JG, Varró A.	Class IB antiarrhythmic property of ranolazine, a novel antianginal agent, in dog and human cardiac preparations.	European Journal of Pharmacology	Eur J Pharmacol. 2011 Jul 15; 662(1-3):31-9.	angol
2011	Koncz I, Szél T, Bitay M, Cerbai E, Jaeger K, Fülöp F, Jost N, Virág L, Orvos P, Tálosi L, Kristóf A, Baczkó I, Papp JG, Varró A.	Electrophysiological Effects of ivabradine in dog and human cardiac preparations: Potential Antiarrhythmic Actions.	European Journal of Pharmacology	Eur J Pharmacol. 2011 Oct 15; 668(3): 419-26.	angol
2011	Varró A, Baczkó I.	Cardiac Ventricular Repolarization Reserve: a principle for understanding drug-related proarrhythmic risk.	British Journal of Pharmacology	Br J Pharmacol. 2011 Sep;164(1):14-36.	angol
2011	Virág L, Jost N, Papp R, Koncz I, Kristóf A, Kohajda Z, Harmati G, Carbonell-Pascual B, Ferrero JM, Papp JG, Nánási PP, Varró A.	Analysis of the contribution of Itotorepolarization in canin Ventricular Myocardium.	British Journal of Pharmacology	Br J Pharmacol. 2011 Sept; 164(1): 93–105.	angol
2012	Kristóf A, Husti Z, KohajdaZs, Szél T, Juhász V, Biliczki P, Jost N, Baczkó I, Papp Gy, Varró A, Virág L.	Diclofenac prolongs repolarization in ventricular muscle with impaired repolarization reserve.	PLoSOne.	PLoSOne. 2012 Dec; 7(12): e53255.	angol